These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 11173813

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Susceptibility of 327 clinical isolates to netilmicin.
    Digranes A, Ostervold B, Madsen ST, Solberg CO, Haeger K.
    J Int Med Res; 1978; 6(5):409-13. PubMed ID: 100353
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the resistance mechanisms of gentamicin-resistant Gram-negative bacilli and their susceptibility to tobramycin, netilmicin and amikacin.
    Maes P.
    J Antimicrob Chemother; 1985 Mar; 15(3):283-9. PubMed ID: 3997704
    [Abstract] [Full Text] [Related]

  • 5. Comparison of postantibiotic effects of imipenem and netilmicin alone and in combination against Pseudomonas aeruginosa.
    Hostacká A.
    Arzneimittelforschung; 1997 Aug; 47(8):965-7. PubMed ID: 9296285
    [Abstract] [Full Text] [Related]

  • 6. New epidemiological data on resistance to netilmicin and other aminoglycosides.
    Toscano MA, Minneci M, Salmeri M, Nicoletti G.
    J Chemother; 1991 Dec; 3(6):352-6. PubMed ID: 1819617
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Resistance of gram-negative bacilli and staphylococci from blood cultures to aminoglycoside antibiotics. Comparison of 3 in vitro investigations from Austria 1982-1988.
    Mittermayer H, Rotter M, Breitfellner G, Riezinger F, Thiel W, Binder L, Watschinger R.
    Zentralbl Bakteriol; 1990 Apr; 272(4):448-57. PubMed ID: 2113808
    [Abstract] [Full Text] [Related]

  • 11. The in vitro activity of gentamicin, tobramycin and netilmicin against 500 clinical isolates of bacteria. A comparative study using three different test media.
    Digranes A, Dibb WL, Benonisen E, Ostervold B.
    Acta Pathol Microbiol Immunol Scand B; 1983 Apr; 91(2):135-9. PubMed ID: 6408889
    [Abstract] [Full Text] [Related]

  • 12. [Sensitivity of bacteria to netilmicin in comparison with their sensitivity to gentamicin and other aminoglycosides].
    Ruczkowska J, Dolna I.
    Przegl Lek; 1988 Apr; 45(4):383-6. PubMed ID: 3145533
    [No Abstract] [Full Text] [Related]

  • 13. In vitro postantibiotic effect and postantibiotic leukocyte enhancement of tobramycin.
    Novelli A, Mazzei T, Fallani S, Cassetta MI, Conti S.
    J Chemother; 1995 Aug; 7(4):355-62. PubMed ID: 8568546
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Postantibiotic effect of aminoglycosides on staphylococci.
    Isaksson B, Maller R, Nilsson LE, Nilsson M.
    J Antimicrob Chemother; 1993 Aug; 32(2):215-22. PubMed ID: 8226423
    [Abstract] [Full Text] [Related]

  • 18. In vitro comparison of combination and monotherapy for the empiric and optimal coverage of bacterial keratitis based on incidence of infection.
    Kowalski RP, Kowalski TA, Shanks RM, Romanowski EG, Karenchak LM, Mah FS.
    Cornea; 2013 Jun; 32(6):830-4. PubMed ID: 23132444
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Evaluation of bactericidal activity of arbekacin in mixed culture with MRSA and Pseudomonas aeruginosa using an in vitro pharmacokinetic simulation system].
    Tsuji A, Sugano T, Yamaguchi K, Goto S, Takada T, Takase Y, Yoshida T.
    Jpn J Antibiot; 1994 Jun; 47(6):655-63. PubMed ID: 8072174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.